Lemaitre Vascular (LMAT) Other Operating Expenses (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Other Operating Expenses for 17 consecutive years, with $4.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Operating Expenses rose 36.88% year-over-year to $4.8 million in Q2 2026; TTM through Jun 2026 was $15.4 million, a 3.35% increase from a year earlier, with the FY2025 full-year figure at $14.1 million, down 9.65% from the prior year.
• Other Operating Expenses was $4.8 million for Q2 2026 at Lemaitre Vascular, up from $4.1 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $4.8 million in Q2 2026 and troughed at $2.9 million in Q1 2022.
• A 5-year average of $3.8 million and a median of $3.8 million in 2023 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses slipped 18.76% in 2025 and soared 36.88% in 2026, its largest moves.
• Over 5 years, Other Operating Expenses stood at $3.6 million in 2022, then rose by 21.76% to $4.3 million in 2023, then declined by 16.56% to $3.6 million in 2024, then declined by 2.35% to $3.5 million in 2025, then surged by 37.19% to $4.8 million in 2026.
• The last three Other Operating Expenses figures came in at $4.8 million (Q2 2026), $4.1 million (Q1 2026), and $3.5 million (Q4 2025), per Business Quant data.